MedPath

The effect of gait training combined with transcranial direct current stimulation in stroke

Not Applicable
Conditions
Diseases of the circulatory system
Registration Number
KCT0007601
Lead Sponsor
Chonnam National University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

1) Patients aged from 20 to 90 years
2) 3 months after ischemic stroke onset
3) hemiplegic patient
4) Functional ambulatory category grade 2~4
5) No difficulty in understanding and communicating with physical therapist
6) Who voluntarily signed an informed consent form for participation in clinical trial

Exclusion Criteria

1) Who is diagnosed or accompanied with stroke other than ischemic type (e.g. hemorrhagic stroke)
2) Who has gait and balance disturbance due to disease other than stroke (e.g. Parkinsonism, neuropathy, myopathy, arthropathy)
3) Who has experienced a seizure or get ongoing treatment for epilepsy
4) Who received medication, procedure or surgery that may affect gait function in last 1 month
5) Who has medical and surgical condition at electrode attachment site
6) Unstable vital signs
7) Who get ongoing treatment for malignancy
8) Who has severe depression and psychiatric disorders that is difficult to adapt the treatment
9) Contraindications to electrostimulation
(1) Metal in head (except in oral cavity)
- cochlear implants, electrode or stimulator, clips or coils for aneurysm, stents, bullet fragments, deep brain stimulator, vagus nerve stimulator, eyeball implant
(2) Who has pacemaker, defibrillator, neurostimulator, drug pump, intracardiac injection line
(3) Who shows continuos seizure event
(4) Who received craniectomy, or ventriculo peritoneal shunt (VP shunt) surgery
(5) Who continuously complains of elevated intracranial pressure symptoms such as headache, vomiting or nausea and others
10) Who has difficulty in communication due to severe aphasia
11) Who has cognitive decline that is difficult to adapt the treatment (Clinical Dementia Rating 1 or more)
12) If other treatments that may affect gait function are performed during the study
13) Pregnant or breast-feeding woman
14) Who are enrolled in other clinical trials
15) Who cannot understand the purpose of the clinical trial or perform treatment protocol
16) Who is thought to be inappropriate to participate in the clinical trial

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
10-meter walking test
Secondary Outcome Measures
NameTimeMethod
MMT(Manual muscle test);TUG(Timed up and go test);FAC(Functional Ambulatory Category);BBS(Berg balance test);K-MBI(K-Modified Barthel Index);European Quality of Life Five Dimension (EQ-5D-3L);Motor evoked potential
© Copyright 2025. All Rights Reserved by MedPath